Larsen, Finn Ole <br/><br/>
Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer.  [electronic resource] 

 -  Acta oncologica (Stockholm, Sweden)  Feb 2012 
 - 231-3 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1651-226X 
<br/><br/><label>Standard No.: </label>10.3109/0284186X.2011.614637  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bevacizumab<br/>Capecitabine<br/>Colorectal Neoplasms--drug therapy<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Survival Analysis<br/>Treatment Outcome